- Home
- VIVS vs TRIB Comparison
VIVS vs TRIB Comparison
Compare VIVS & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- TRIB
- Stock Information
- Founded
- VIVS 2007
- TRIB 1992
- Country
- VIVS United States
- TRIB Ireland
- Employees
- VIVS N/A
- TRIB N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VIVS Health Care
- TRIB Health Care
- Exchange
- VIVS Nasdaq
- TRIB Nasdaq
- Market Cap
- VIVS 4.7M
- TRIB 5.4M
- IPO Year
- VIVS N/A
- TRIB N/A
- Fundamental
- Price
- VIVS $3.19
- TRIB $1.07
- Analyst Decision
- VIVS
- TRIB
- Analyst Count
- VIVS 0
- TRIB 0
- Target Price
- VIVS N/A
- TRIB N/A
- AVG Volume (30 Days)
- VIVS 166.7K
- TRIB 109.3K
- Earning Date
- VIVS 11-07-2025
- TRIB 11-14-2025
- Dividend Yield
- VIVS N/A
- TRIB N/A
- EPS Growth
- VIVS N/A
- TRIB N/A
- EPS
- VIVS N/A
- TRIB N/A
- Revenue
- VIVS $142,000.00
- TRIB $61,555,000.00
- Revenue This Year
- VIVS $42.38
- TRIB $13.51
- Revenue Next Year
- VIVS $15.42
- TRIB $13.14
- P/E Ratio
- VIVS N/A
- TRIB N/A
- Revenue Growth
- VIVS 94.52
- TRIB 8.31
- 52 Week Low
- VIVS $1.41
- TRIB $0.48
- 52 Week High
- VIVS $21.96
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- VIVS 51.15
- TRIB 44.32
- Support Level
- VIVS $2.90
- TRIB $1.00
- Resistance Level
- VIVS $3.48
- TRIB $1.17
- Average True Range (ATR)
- VIVS 0.34
- TRIB 0.07
- MACD
- VIVS -0.09
- TRIB -0.01
- Stochastic Oscillator
- VIVS 20.86
- TRIB 27.96
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.